Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Ashok Jain

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Procedures

Chemicals & Drugs

Physiology

Concepts & Ideas

Anatomy

Kidney
Liver

Living Beings

Living Donors

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Kashyap Randeep; Mantry Parvez; Sharma Rajeev; Maloo Manoj K; Safadjou Saman; Qi Yanjie; Jain Ashok; Maliakkal Benedict; Ryan Charlotte; Orloff Mark
Comparative analysis of outcomes in living and deceased donor liver transplants for primary sclerosing cholangitis.
Jain Ashok; Patil Vrishali P; Horton Peter; Patel Nikhil; Kashyap Randeep; Tsoulfas Georgios; Orloff Mark; Bozorgzadeh Adel
Common iliac artery lying posterior to psoas major identified during kidney transplantation.
Kashyap Randeep; Bozorgzadeh Adel; Abt Peter; Tsoulfas Georgios; Maloo Manoj; Sharma Rajeev; Patel Siddharth; Dombroski David; Mantry Parvez; Safadjou Saman; Jain Ashok; Orloff Mark
Stratifying risk of biliary complications in adult living donor liver transplantation by magnetic resonance cholangiography.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Ashok Jain (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Kashyap Randeep; Mantry Parvez; Sharma Rajeev; Maloo Manoj K; Safadjou Saman; Qi Yanjie; Jain Ashok; Maliakkal Benedict; Ryan Charlotte; Orloff Mark
Comparative analysis of outcomes in living and deceased donor liver transplants for primary sclerosing cholangitis.
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 2009;13(8):1480-6.
2008: Jain Ashok; Patil Vrishali P; Horton Peter; Patel Nikhil; Kashyap Randeep; Tsoulfas Georgios; Orloff Mark; Bozorgzadeh Adel
Common iliac artery lying posterior to psoas major identified during kidney transplantation.
Transplantation 2008;86(4):623-4.
2008: Kashyap Randeep; Bozorgzadeh Adel; Abt Peter; Tsoulfas Georgios; Maloo Manoj; Sharma Rajeev; Patel Siddharth; Dombroski David; Mantry Parvez; Safadjou Saman; Jain Ashok; Orloff Mark
Stratifying risk of biliary complications in adult living donor liver transplantation by magnetic resonance cholangiography.
Transplantation 2008;85(11):1569-72.
2008: Jain Ashok; Venkataramanan Raman; Sharma Rajeev; Kwong Tai; Abt Peter; Orloff Mark; Kashyap Randeep; Tsoulfas Georgious; Bozorgzadeh Adel
Pharmacokinetics of mycophenolic acid in live donor liver transplant patients vs deceased donor liver transplant patients.
Journal of clinical pharmacology 2008;48(5):547-52.
2008: Patel Siddharth; Cassuto James; Orloff Mark; Tsoulfas Georgios; Zand Martin; Kashyap Randeep; Jain Ashok; Bozorgzadeh Adel; Abt Peter
Minimizing morbidity of organ donation: analysis of factors for perioperative complications after living-donor nephrectomy in the United States.
Transplantation 2008;85(4):561-5.
2008: Jain Ashok; Venkataramanan Raman; Sharma Rajeev; Kwong Tai; Orloff Mark; Abt Peter; Kashyap Randeep; Tsoulfas Georgious; Batzold Pam; Williamson Mary; Bozorgzadeh Adel
Pharmacokinetics of tacrolimus in living donor liver transplant and deceased donor liver transplant recipients.
Transplantation 2008;85(4):554-60.
2007: Nickels Mark; Jain Ashok; Sharma Rajeev; Orloff Mark; Tsoulfas Georgios; Kashyap Randeep; Bozorgzadeh Adel
Polysubstance abuse in liver transplant patients and its impact on survival outcome.
Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 2007;5(2):680-5.
2007: Patel S; Orloff M; Tsoulfas G; Kashyap R; Jain A; Bozorgzadeh A; Abt P
Living-donor liver transplantation in the United States: identifying donors at risk for perioperative complications.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2007;7(10):2344-9.
2007: Bozorgzadeh Adel; Orloff Mark; Abt Peter; Tsoulfas Georgios; Younan Durald; Kashyap Randeep; Jain Ashok; Mantry Parvez; Maliakkal Benedict; Khorana Alok; Schwartz Seymour
Survival outcomes in liver transplantation for hepatocellular carcinoma, comparing impact of hepatitis C versus other etiology of cirrhosis.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2007;13(6):807-13.
2007: Jain Ashok; Venkataramanan Raman; Kwong Tai; Mohanka Ravi; Orloff Mark; Abt Peter; Kashyap Randeep; Tsoulfas Georgios; Mack Cindy; Williamson Mary; Batzold Pam; Bozorgzadeh Adel
Pharmacokinetics of mycophenolic acid in liver transplant patients after intravenous and oral administration of mycophenolate mofetil.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2007;13(6):791-6.
2006: Jain Ashok; Orloff Mark; Abt Peter; Kashyap Randeep; Mantry Parvez; Bozorgzadeh Adel
Postoperative impact of intraoperative biochemical changes at the completion of parenchymal division in living-donor liver transplantation.
Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 2006;4(2):544-8.
2006: Abt Peter; Kashyap Randeep; Orloff Mark; Jain Ashok; Tsoulfas George; Bozorgzadeh Adel; Olthoff Kim
Pediatric liver and kidney transplantation with allografts from DCD donors: A review of UNOS data.
Transplantation 2006;82(12):1708-11.
2006: de Vera M E; Dvorchik I; Tom K; Eghtesad B; Thai N; Shakil O; Marcos A; Demetris A; Jain A; Fung J J; Ragni M V
Survival of liver transplant patients coinfected with HIV and HCV is adversely impacted by recurrent hepatitis C.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2006;6(12):2983-93.
2006: Jain Ashok; Ryan Charlotte; Mohanka Ravi; Orloff Mark; Abt Peter; Romano Joan; Bryan Leah; Batzold Pam; Mantry Parvez; Bozorgzadeh Adel
Characterization of CD4, CD8, CD56 positive lymphocytes and C4d deposits to distinguish acute cellular rejection from recurrent hepatitis C in post-liver transplant biopsies.
Clinical transplantation 2006;20(5):624-33.
2006: Maloo M; Abt P; Kashyap R; Younan D; Zand M; Orloff M; Jain A; Pentland A; Scott G; Bozorgzadeh A
Nephrogenic systemic fibrosis among liver transplant recipients: a single institution experience and topic update.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2006;6(9):2212-7.
2006: Angona Ron; Abt Peter; Younan Duraid; Massey Todd; Marvin Michael; Kashyap Randeep; Richards Dan; Jones Karen; Queschenbach James; Zand Martin; Jain Ashok; Orloff Mark; Bozorgzadeh Adel
Modification of a biventricular assist device to facilitate preservative infusion and organ recovery in a nonheart-beating donor.
The Journal of extra-corporeal technology 2006;38(2):157-60.
2006: Jain Ashok; Menegus Marilyn; Mohanka Ravi; Orloff Mark; Abt Peter; Mantry Parvez; Bozorgzadeh Adel
HCV antibody quantitative levels in liver transplant patients: do they have any relevance in clinical practice?
Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 2006;4(1):475-80.
2006: Jain Ashok; Mohanka Ravi; Orloff Mark; Abt Peter; Kashyap Randeep; Cullen Jackie; Lansing Kerrie; Bozorgzadeh Adel
University of Wisconsin versus histidine-tryptophan-ketoglutarate for tissue preservation in live-donor liver transplantation.
Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 2006;4(1):451-7.
2006: Jain Ashok; Mohanka Ravi; Orloff Mark; Abt Peter; Ryan Charlotte; Bozorgzadeh Adel
Question of using valganciclovir for cytomegalovirus (CMV) infection prophylaxis in post-liver transplant recipients.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2006;12(6):1020-1; author reply 1022-3.
2006: DiMartini Andrea; Day Nancy; Dew Mary Amanda; Javed Lubna; Fitzgerald Mary Grace; Jain Ashok; Fung John J; Fontes Paulo
Alcohol consumption patterns and predictors of use following liver transplantation for alcoholic liver disease.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2006;12(5):813-20.
2005: Jain Ashok; Mohanka Ravi; Orloff Mark; Abt Peter; Kashyap Randeep; Kelley Mark; Burlee Kari; Bozorgzadeh Adel
Intravenous mycophenolate mofetil with low-dose oral tacrolimus and steroid induction for live donor liver transplantation.
Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 2005;3(2):361-5.
2005: Jain A; Vekatramanan R; Yelochan B; Kashyap R; Marcos A; Fung J
Ribavirin levels in post liver transplant patients treated for recurrent hepatitis C viral infection.
Transplantation proceedings 2005;37(7):3190-6.
2005: Jain A; Orloff M; Abt P; Kashyap R; Mohanka R; Lansing K; Kelley M; Bozorgzadeh A
Use of hepatitis B core antibody-positive liver allograft in hepatitis C virus-positive and -negative recipients with use of short course of hepatitis B immunoglobulin and Lamivudine.
Transplantation proceedings 2005;37(7):3187-9.
2005: Jain A; Orloff M; Kashyap R; Lansing K; Betts R; Mohanka R; Menegus M; Ryan C; Bozorgzadeh A
Does valganciclovir hydrochloride (valcyte) provide effective prophylaxis against cytomegalovirus infection in liver transplant recipients?
Transplantation proceedings 2005;37(7):3182-6.
2005: Jain A; Orloff M; Abt P; Kashyap R; Mohanka R; Lansing K; Bozorgzadeh A
Transplantation of liver grafts from older donors: impact on recipients with hepatitis C virus infection.
Transplantation proceedings 2005;37(7):3162-4.
2005: Jain A; Orloff M; Abt P; Kashyap R; Mohanka R; Lansing K; Romano J; Bozorgzadeh A
Survival outcome after hepatic retransplantation for hepatitis C virus-positive and -negative recipients.
Transplantation proceedings 2005;37(7):3159-61.
2005: Shah Amish; Kendall Gwen; Demme Richard A; Taylor Jeremy; Bozorgzadeh Adel; Orloff Mark; Jain Ashok; Abt Peter; Zand Martin S
Home glucometer monitoring markedly improves diagnosis of post renal transplant diabetes mellitus in renal transplant recipients.
Transplantation 2005;80(6):775-81.
2005: DiMartini Andrea; Javed Lubna; Russell Sarah; Dew Mary Amanda; Fitzgerald Mary Grace; Jain Ashok; Fung John
Tobacco use following liver transplantation for alcoholic liver disease: an underestimated problem.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2005;11(6):679-83.
2005: Jain A; Marcos A; Reyes J; Mazariagos G; Kashyap R; Eghtesad B; Marsh W; Fontas P; De Vera M; Costa G; Patel K; Gadomski M; Starzl T; Fung J
Tacrolimus for primary liver transplantation: 12 to 15 years actual follow-up with safety profile.
Transplantation proceedings 2005;37(2):1207-10.
2005: Pisupati Jaya; Jain Ashok; Burckart Gilbert; Hamad Imad; Zuckerman Sheila; Fung John; Venkataramanan Raman
Intraindividual and interindividual variations in the pharmacokinetics of mycophenolic acid in liver transplant patients.
Journal of clinical pharmacology 2005;45(1):34-41.
2004: DiMartini Andrea; Dew Mary Amanda; Javed Lubna; Fitzgerald Mary Grace; Jain Ashok; Day Nancy
Pretransplant psychiatric and medical comorbidity of alcoholic liver disease patients who received liver transplant.
Psychosomatics 2004;45(6):517-23.
2004: Bozorgzadeh Adel; Jain Ashok; Ryan Charlotte; Ornt Daniel; Zand Martin; Mantry Parvez; Lansing Kerrie; Orloff Mark
Impact of hepatitis C viral infection in primary cadaveric liver allograft versus primary living-donor allograft in 100 consecutive liver transplant recipients receiving tacrolimus.
Transplantation 2004;77(7):1066-70.
2003: Luke Patrick P W; Herz Daniel B; Bellinger Mark F; Chakrabarti Pradip; Vivas Carlos A; Scantlebury Velma P; Hakala Thomas R; Jevnikar Anthony M; Jain Ashok; Shapiro Ron; Jordan Mark L
Long-term results of pediatric renal transplantation into a dysfunctional lower urinary tract.
Transplantation 2003;76(11):1578-82.
2003: Eghtesad Bijan; Marsh Wallis J; Cacciarelli Thomas; Geller David; Reyes Jorge; Jain Ashok; Fontes Paulo; Devera Michael; Fung John
Liver transplantation for growing teratoma syndrome: report of a case.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2003;9(11):1222-4.
2003: Jain Ashok; Mazariegos George; Pokharna Renu; Parizhskaya Maria; Kashyap Randeep; Kosmach-Park Beverly; Smith Amy; Fung John J; Reyes Jorge
The absence of chronic rejection in pediatric primary liver transplant patients who are maintained on tacrolimus-based immunosuppression: a long-term analysis.
Transplantation 2003;75(7):1020-5.
2002: Demetris A J; Ruppert K; Dvorchik I; Jain A; Minervini M; Nalesnik M A; Randhawa P; Wu T; Zeevi A; Abu-Elmagd K; Eghtesad B; Fontes P; Cacciarelli T; Marsh W; Geller D; Fung J J
Real-time monitoring of acute liver-allograft rejection using the Banff schema.
Transplantation 2002;74(9):1290-6.
2002: Jain Ashok; Nalesnik Mike; Reyes Jorge; Pokharna Renu; Mazariegos George; Green Michael; Eghtesad Bijan; Marsh Wallis; Cacciarelli Thomas; Fontes Paulo; Abu-Elmagd Kareem; Sindhi Rakesh; Demetris Jake; Fung John
Posttransplant lymphoproliferative disorders in liver transplantation: a 20-year experience.
Annals of surgery 2002;236(4):429-36; discussion 436-7.
2002: Jain A; Mazariegos G; Pokharna R; Parizhskaya M; Smith A; Kashyap R; Fung J J; Reyes J
Almost total absence of chronic rejection in primary pediatric liver transplantation under tacrolimus.
Transplantation proceedings 2002;34(5):1968-9.
2002: Jain A; Mazariegos G; Kashyap R; Kosmach-Park B; Starzl T E; Fung J J; Reyes J
Pediatric liver transplantation in 808 consecutive children: 20-years experience from a single center.
Transplantation proceedings 2002;34(5):1955-7.
2002: Shapiro R; Scantlebury V P; Jordan M L; Vivas C A; Jain A; Hakala T R; McCauley J; Johnston J; Randhawa P; Fedorek S; Gray E; Chesky A; Dvorchik I; Donaldson J; Fung J J; Starzl T E
A pilot trial of tacrolimus, sirolimus, and steroids in renal transplant recipients.
Transplantation proceedings 2002;34(5):1651-2.
2002: Jain Ashok; Pokharna R; Eghtesad B; Potdar S; Kashyap R; Kingery L; Fung J
Steroid withdrawal under tacrolimus for primary biliary cirrhosis, primary sclerosing cholangitis and autoimmune hepatitis after liver transplantation and long-term survival.
Transplantation proceedings 2002;34(5):1524-5.
2002: Agarwala Sangeeta; Culligan Emma; Jain Ashok; McCauley Jerry; Shapiro Ron; Chakrabarti Pradip; Burckart Gilbert; Venkataramanan Raman
Evaluation of renal function in transplant patients on tacrolimus therapy.
Journal of clinical pharmacology 2002;42(7):798-805.
2002: Jain Ashok; Mazariegos George; Kashyap Randeep; Kosmach-Park Beverly; Starzl T E; Fung John; Reyes Jorge
Pediatric liver transplantation. A single center experience spanning 20 years.
Transplantation 2002;73(6):941-7.
2002: Shullo Michael A; Rose Meredith L; Vivas Carlos; Jordan Mark L; Scantlebury Velma P; Jain Ashok; Corry Robert J; Fung John J; McCauley Jerry; Johnston James; Shapiro Ron
Hemorrhagic complications of enoxaparin and aspirin in patients with kidney transplants.
Pharmacotherapy 2002;22(2):184-7.
2002: Jain Ashok; Kashyap Randeep; Demetris Anthony J; Eghstesad Bijan; Pokharna Renu; Fung John J
A prospective randomized trial of mycophenolate mofetil in liver transplant recipients with hepatitis C.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2002;8(1):40-6.
2001: Fung J J; Jain A; Kwak E J; Kusne S; Dvorchik I; Eghtesad B
De novo malignancies after liver transplantation: a major cause of late death.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2001;7(11 Suppl 1):S109-18.
2001: Cacciarelli T V; Reyes J; Jaffe R; Mazariegos G V; Jain A; Fung J J; Green M
Primary tacrolimus (FK506) therapy and the long-term risk of post-transplant lymphoproliferative disease in pediatric liver transplant recipients.
Pediatric transplantation 2001;5(5):359-64.
2001: Jain A; Kashyap R; Dodson F; Kramer D; Hamad I; Khan A; Eghestad B; Starzl T E; Fung J J
A prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone and mycophenolate mofetil in primary adult liver transplantation: a single center report.
Transplantation 2001;72(6):1091-7.
2001: Luke P P; Scantlebury V P; Jordan M L; Vivas C A; Hakala T R; Jain A; Somani A; Fedorek S; Randhawa P; Shapiro R
Reversal of steroid- and anti-lymphocyte antibody-resistant rejection using intravenous immunoglobulin (IVIG) in renal transplant recipients.
Transplantation 2001;72(3):419-22.
2001: Jain A; Demetris A J; Kashyap R; Blakomer K; Ruppert K; Khan A; Rohal S; Starzl T E; Fung J J
Does tacrolimus offer virtual freedom from chronic rejection after primary liver transplantation? Risk and prognostic factors in 1,048 liver transplantations with a mean follow-up of 6 years.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2001;7(7):623-30.
2001: Shapiro R; Randhawa P; Jordan M L; Scantlebury V P; Vivas C; Jain A; Corry R J; McCauley J; Johnston J; Donaldson J; Gray E A; Dvorchik I; Hakala T R; Fung J J; Starzl T E
An analysis of early renal transplant protocol biopsies--the high incidence of subclinical tubulitis.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2001;1(1):47-50.
2001: Venkataramanan R; Shaw L M; Sarkozi L; Mullins R; Pirsch J; MacFarlane G; Scheller D; Ersfeld D; Frick M; Fitzsimmons W E; Virji M; Jain A; Brayman K L; Shaked A
Clinical utility of monitoring tacrolimus blood concentrations in liver transplant patients.
Journal of clinical pharmacology 2001;41(5):542-51.
2001: Jain A; Kashyap R; Marsh W; Rohal S; Khanna A; Fung J J
Reasons for long-term use of steroid in primary adult liver transplantation under tacrolimus.
Transplantation 2001;71(8):1102-6.
2001: Jain A; Mazariegos G; Kashyap R; Marsh W; Khanna A; Iurlano K; Fung J; Reyes J
Reasons why some children receiving tacrolimus therapy require steroids more than 5 years post liver transplantation.
Pediatric transplantation 2001;5(2):93-8.
2001: Jain A; Venkataramanan R; Hamad I S; Zuckerman S; Zhang S; Lever J; Warty V S; Fung J J
Pharmacokinetics of mycophenolic acid after mycophenolate mofetil administration in liver transplant patients treated with tacrolimus.
Journal of clinical pharmacology 2001;41(3):268-76.
2001: Randhawa P; Blakolmer K; Kashyap R; Raikow R; Nalesnik M; Demetris A J; Jain A
Allograft liver biopsy in patients with Epstein-Barr virus-associated posttransplant lymphoproliferative disease.
The American journal of surgical pathology 2001;25(3):324-30.
2001: McCauley J; Shapiro R; Jordan M L; Scantlebury V P; Vivas C; Jain A; Good D; Woods H; Johnston J; Corry R J
Long-term lipid metabolism in combined kidney-pancreas transplant recipients under tacrolimus immunosuppression.
Transplantation proceedings 2001;33(1-2):1698-9.
2001: Kashyap R; Jain A; Reyes J; Demetris A J; Elmagd K A; Dodson S F; Marsh W; Madariaga V; Mazariegos G; Geller D; Bonham C A; Cacciarelli T; Fontes P; Starzl T E; Fung J J
Causes of retransplantation after primary liver transplantation in 4000 consecutive patients: 2 to 19 years follow-up.
Transplantation proceedings 2001;33(1-2):1486-7.
2001: Kashyap R; Jain A; Reyes J; Demetris A J; Elmagd K A; Dodson S F; Marsh W; Madariaga V; Mazariegos G; Geller D; Bonham C A; Cacciarelli T; Fontes P; Starzl T E; Fung J J
Causes of death after liver transplantation in 4000 consecutive patients: 2 to 19 year follow-up.
Transplantation proceedings 2001;33(1-2):1482-3.
2001: Jain A; Kashyap R; Kramer D; Dodson F; Hamad I; Starzl T E; Fung J J
Prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone, and mycophenolate mofetil: complete report on 350 primary adult liver transplantations.
Transplantation proceedings 2001;33(1-2):1342-4.
2001: Shapiro R; Rao A S; Corry R J; Valenti M; Zeevi A; Jordan M L; Scantlebury V P; Vivas C A; Jain A; McCauley J; Randhawa P; Gray E A; Dvorchik I; McMichael J; Fung J J; Starzl T E
Kidney transplantation with bone marrow augmentation: five-year outcomes.
Transplantation proceedings 2001;33(1-2):1134-5.
2001: Luke P P; Scantlebury V P; Jordan M L; Vivas C A; Hakala T R; Jain A; Somani A; Fedorek S; Randhawa P; Shapiro R
IVIG rescue therapy in renal transplantation.
Transplantation proceedings 2001;33(1-2):1093-4.
2001: DiMartini A; Day N; Dew M A; Lane T; Fitzgerald M G; Magill J; Jain A
Alcohol use following liver transplantation: a comparison of follow-up methods.
Psychosomatics 2001;42(1):55-62.
2001: Mazariegos G V; Salzedas A A; Jain A; Reyes J
Conversion from cyclosporin to tacrolimus in paediatric liver transplant recipients.
Paediatric drugs 2001;3(9):661-72.
2000: Jain A; DiMartini A; Kashyap R; Youk A; Rohal S; Fung J
Long-term follow-up after liver transplantation for alcoholic liver disease under tacrolimus.
Transplantation 2000;70(9):1335-42.
2000: Jain A; Reyes J; Kashyap R; Dodson S F; Demetris A J; Ruppert K; Abu-Elmagd K; Marsh W; Madariaga J; Mazariegos G; Geller D; Bonham C A; Gayowski T; Cacciarelli T; Fontes P; Starzl T E; Fung J J
Long-term survival after liver transplantation in 4,000 consecutive patients at a single center.
Annals of surgery 2000;232(4):490-500.
2000: Jain A; Mazariegos G; Kashyap R; Green M; Gronsky C; Starzl T E; Fung J; Reyes J
Comparative long-term evaluation of tacrolimus and cyclosporine in pediatric liver transplantation.
Transplantation 2000;70(4):617-25.
2000: DiMartini A; Magill J; Fitzgerald M G; Jain A; Irish W; Khera G; Yates W
Use of a high-risk alcohol relapse scale in evaluating liver transplant candidates.
Alcoholism, clinical and experimental research 2000;24(8):1198-201.
2000: Reyes J; Jain A; Mazariegos G; Kashyap R; Green M; Iurlano K; Fung J
Long-term results after conversion from cyclosporine to tacrolimus in pediatric liver transplantation for acute and chronic rejection.
Transplantation 2000;69(12):2573-80.
2000: Blakolmer K; Jain A; Ruppert K; Gray E; Duquesnoy R; Murase N; Starzl T E; Fung J J; Demetris A J
Chronic liver allograft rejection in a population treated primarily with tacrolimus as baseline immunosuppression: long-term follow-up and evaluation of features for histopathological staging.
Transplantation 2000;69(11):2330-6.
2000: Shapiro R; Jordan M L; Scantlebury V P; Vivas C A; Jain A; McCauley J; Egidi M F; Randhawa P; Chakrabarti P; Corry R J
Renal allograft rejection with normal renal function in simultaneous kidney/pancreas recipients: does dissynchronous rejection really exist?
Transplantation 2000;69(3):440-1.
2000: Jain A; Brody D; Hamad I; Rishi N; Kanal E; Fung J
Conversion to neoral for neurotoxicity after primary adult liver transplantation under tacrolimus.
Transplantation 2000;69(1):172-6.
1999: Shapiro R; Nalesnik M; McCauley J; Fedorek S; Jordan M L; Scantlebury V P; Jain A; Vivas C; Ellis D; Lombardozzi-Lane S; Randhawa P; Johnston J; Hakala T R; Simmons R L; Fung J J; Starzl T E
Posttransplant lymphoproliferative disorders in adult and pediatric renal transplant patients receiving tacrolimus-based immunosuppression.
Transplantation 1999;68(12):1851-4.
1999: Jain A; Reyes J; Kashyap R; Rohal S; Abu-Elmagd K; Starzl T; Fung J
What have we learned about primary liver transplantation under tacrolimus immunosuppression? Long-term follow-up of the first 1000 patients.
Annals of surgery 1999;230(3):441-8; discussion 448-9.
1999: Shapiro R; Jordan M L; Scantlebury V P; Vivas C A; Jain A; Chakrabarti P; McCauley J; Johnston J; Randhawa P; Rao A; Fung J J; Corry R J
Simultaneous pancreas-kidney transplantation at the University of Pittsburgh.
Clinical transplants 1999;():217-21.
1998: DiMartini A; Jain A; Irish W; Fitzgerald M G; Fung J
Outcome of liver transplantation in critically ill patients with alcoholic cirrhosis: survival according to medical variables and sobriety.
Transplantation 1998;66(3):298-302.
1998: Jain A; Reyes J; Kashyap R; Rohal S; Cacclarelli T; McMichael J; Rakela J; Starzl T E; Fung J J
Liver transplantation under tacrolimus in infants, children, adults, and seniors: long-term results, survival, and adverse events in 1000 consecutive patients.
Transplantation proceedings 1998;30(4):1403-4.
1998: Jain A; Demetris A J; Manez R; Tsamanadas A C; Van Thiel D; Rakela J; Starzl T E; Fung J J
Incidence and severity of acute allograft rejection in liver transplant recipients treated with alfa interferon.
Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 1998;4(3):197-203.
1998: Abu-Elmagd K; Fung J; Reyes J; Rao A; Jain A; Mazariegos G; Marsh W; Madariaga J; Dvorchik I; Bueno J; Rogers J; McMichael J; Dodson F; Vargus H; Martin J; Slivka A; Balan V; Corry R; Rakela J; Murase N; Demetris J; Iwatsuki S; Starzl T
Hepatic and intestinal transplantation at the University of Pittsburgh.
Clinical transplants 1998;():263-86.
1997: Jain A; Venkataramanan R; Fung J J; Gartner J C; Lever J; Balan V; Warty V; Starzl T E
Pregnancy after liver transplantation under tacrolimus.
Transplantation 1997;64(4):559-65.
1997: Khanna A; Jain A; Ziady G; Demetris A J; Fung J J; Kramer D; Starzl T E
Cardiac changes at autopsy in adult liver transplant recipients under tacrolimus.
Transplantation proceedings 1997;29(1-2):532-3.
1997: Tabasco-Minguillán J; Jain A; Naik M; Weber K M; Irish W; Fung J J; Rakela J; Starzl T E
Gastrointestinal bleeding after liver transplantation.
Transplantation 1997;63(1):60-7.
1995: Venkataramanan R; Swaminathan A; Prasad T; Jain A; Zuckerman S; Warty V; McMichael J; Lever J; Burckart G; Starzl T
Clinical pharmacokinetics of tacrolimus.
Clinical pharmacokinetics 1995;29(6):404-30.
1995: Bronsther O; Mañez R; Kusne S; Irish W; Roland W; Jain A; Llull R; Demetris A J; Starzl T E
Posttransplant B, non-A non-B, and cytomegalovirus hepatitis increase the risk of developing chronic rejection after liver transplantation.
Transplantation proceedings 1995;27(1):1206-7.
1995: Shapiro R; Jordan M L; Scantlebury V P; Vivas C; Fung J J; McCauley J; Randhawa P; Demetris A J; Irish W; Jain A
A prospective, randomized trial of FK 506/prednisone vs FK 506/azathioprine/prednisone in renal transplant patients.
Transplantation proceedings 1995;27(1):814-7.
1994: Todo S; Fung J J; Starzl T E; Tzakis A; Doyle H; Abu-Elmagd K; Jain A; Selby R; Bronsther O; Marsh W
Single-center experience with primary orthotopic liver transplantation with FK 506 immunosuppression.
Annals of surgery 1994;220(3):297-308; discussion 308-9.
1994: Jain A; Venkataramanan R; Lever J; Warty V; Abu-Elmagd K; Furukawa H; Reyes J; Nour B; Asrian A; Tzakis A
FK 506 in small bowel transplant recipients: pharmacokinetics and dosing.
Transplantation proceedings 1994;26(3):1609-10.
1994: Mañez R; Martin M; Raman D; Silverman D; Jain A; Warty V; Gonzalez-Pinto I; Kusne S; Starzl T E
Fluconazole therapy in transplant recipients receiving FK506.
Transplantation 1994;57(10):1521-3.
1993: Jain A; Venkataramanan R; Lever J; Warty V; Fung J; Todo S; Starzl T
FK506 and pregnancy in liver transplant patients.
Transplantation 1993;56(6):1588-9.
1993: Fung J; Todo S; Abu-Elmagd K; Jain A; Tzakis A; Martin M; Selby R; Bronsther O; Doyle H; Gayowski T
Randomized trial in primary liver transplantation under immunosuppression with FK 506 or cyclosporine.
Transplantation proceedings 1993;25(1 Pt 2):1130.
1993: Alessiani M; Cillo U; Fung J J; Irish W; Abu-Elmagd K; Jain A; Takaya S; Van Thiel D; Starzl T E
Adverse effects of FK 506 overdosage after liver transplantation.
Transplantation proceedings 1993;25(1 Pt 1):628-34.
1993: Abu-Elmagd K; Bronsther O; Jain A; Irish W; Ramos H; Marino I R; Dodson F; Selby R; Doyle H; Furukawa H
Recent advances in hepatic transplantation at the University of Pittsburgh.
Clinical transplants 1993;():137-52.
1992: Reyes J; Abu-Elmagd K; Tzakis A; Nour B; Casavilla A; Kusne S; Green M; Alessiani M; Jain A; Fung J J
Infectious complications after human small bowel transplantation.
Transplantation proceedings 1992;24(3):1249-50.
1992: Jain A; Venkataramanan R; Todo S; Abu-Elmagd K; Fung J; Warty V; Tzakis A; Reyes J; Alessiani M; Starzl T E
Intravenous, oral pharmacokinetics, and oral dosing of FK 506 in small bowel transplant patients.
Transplantation proceedings 1992;24(3):1181-2.
1992: Demetris A J; Fung J J; Todo S; McCauley J; Jain A; Takaya S; Alessiani M; Abu-Elmagd K; Van Thiel D H; Starzl T E
Conversion of liver allograft recipients from cyclosporine to FK506 immunosuppressive therapy--a clinicopathologic study of 96 patients.
Transplantation 1992;53(5):1056-62.
1992: Todo S; Tzakis A G; Abu-Elmagd K; Reyes J; Fung J J; Casavilla A; Nakamura K; Yagihashi A; Jain A; Murase N
Cadaveric small bowel and small bowel-liver transplantation in humans.
Transplantation 1992;53(2):369-76.
1992: Kusne S; Fung J; Alessiani M; Martin M; Torre-Cisneros J; Irish W; Ondick L; Jain A; Abu-Elmagd K; Takaya S
Infections during a randomized trial comparing cyclosporine to FK 506 immunosuppression in liver transplantation.
Transplantation proceedings 1992;24(1):429-30.
1991: Demetris A J; Fung J J; Todo S; McCauley J; Jain A; Takaya S; Alessiani M; Abu-Elmagd K; Van Thiel D H; Starzl T E
FK 506 used as rescue therapy for human liver allograft recipients.
Transplantation proceedings 1991;23(6):3005-6.
1991: Eidelman B H; Abu-Elmagd K; Wilson J; Fung J J; Alessiani M; Jain A; Takaya S; Todo S N; Tzakis A; Van Thiel D
Neurologic complications of FK 506.
Transplantation proceedings 1991;23(6):3175-8.
1991: McCauley J; Fung J J; Brown H; Deballi P; Jain A; Todo S; Starzl T E
Renal function after conversion from cyclosporine to FK 506 in liver transplant patients.
Transplantation proceedings 1991;23(6):3148-9.
1991: Tauxe W N; Mochizuki T; McCauley J; Starzl T E; Jain A; Charron M
A comparison of the renal effects (ERPF, GFR, and FF) of FK 506 and cyclosporine in patients with liver transplantation.
Transplantation proceedings 1991;23(6):3146-7.
1991: McCauley J; Fung J J; Todo S; Jain A; Deballi P; Starzl T E
Changes in renal function after liver transplantation under FK 506.
Transplantation proceedings 1991;23(6):3143-5.
1991: Fung J J; Alessiani M; Abu-Elmagd K; Todo S; Shapiro R; Tzakis A; Van Thiel D; Armitage J; Jain A; McCauley J
Adverse effects associated with the use of FK 506.
Transplantation proceedings 1991;23(6):3105-8.
1991: Jordan M L; Shapiro R; Jensen C W; Scantlebury V; Fung J; Tzakis A; McCauley J; Jain A; Demetrius J; Randhawa P
FK 506 conversion of renal allografts failing cyclosporine immunosuppression.
Transplantation proceedings 1991;23(6):3078-81.
1991: McCauley J; Shapiro R; Bronster O; Jordan M; Ellis D; Gilboa N; Scantlebury V; Jensen C; Jain A; Starzl T
Renal transplantation under FK 506 in patients with previous loss of renal function due to hemolytic uremic syndrome.
Transplantation proceedings 1991;23(6):3068-70.
1991: Whiteside T L; Wilson J; Bryant J; Zeevi A; Abu el-Magd K; Jain A; Alessiani M; Fung J; Herberman R B; Starzl T E
Serial monitoring of immunologic function and phenotype of lymphocytes in the blood of transplanted patients randomized to cyclosporine or FK 506.
Transplantation proceedings 1991;23(6):3047-51.
1991: Alessiani M; Kusne S; Fung J J; Torre-Cisneros J; Jain A; Abu-Elmagd K; Takaya S; Cillo U; Martin M; Todo S
CMV infection in liver transplantation under cyclosporine or FK 506 immunosuppression.
Transplantation proceedings 1991;23(6):3035-7.
1991: Felser I; Wagner S; Depee J; Johnson N; Staschak S; Jain A; Fung J J; Starzl T E
Changes in quality of life following conversion from CyA to FK 506 in orthotopic liver transplant patients.
Transplantation proceedings 1991;23(6):3032-4.
1991: Takaya S; Bronsther O; Todo S; Abu-Elmagd K; Jain A; Alessiani M; Madariaga J; Marino I R; Selby R; Fung J J
Retransplantation of liver: a comparison of FK 506- and cyclosporine-treated patients.
Transplantation proceedings 1991;23(6):3026-8.
1991: Tzakis A G; Reyes J; Todo S; Green M; Ohya T; Jain A; Abu-Elmagd K; Alessiani M; Fung J J; Starzl T E
FK 506 versus cyclosporine in pediatric liver transplantation.
Transplantation proceedings 1991;23(6):3010-5.
1991: Fung J; Abu-Elmagd K; Jain A; Gordon R; Tzakis A; Todo S; Takaya S; Alessiani M; Demetris A; Bronster O
A randomized trial of primary liver transplantation under immunosuppression with FK 506 vs cyclosporine.
Transplantation proceedings 1991;23(6):2977-83.
1991: Zeevi A; Venkataramanan R; Warty V; Eiras G; Woan M; Abu-Elmagd K; Alessiani M; Jain A; Demetris A J; Zerbe T
In vitro assessment of FK 506 immunosuppressive activity in transplant patients.
Transplantation proceedings 1991;23(6):2897-9.
1991: Abu-Elmagd K M; Fung J J; Alessiani M; Jain A; Takaya S; Venkataramanan R; Warty V S; Shannon W; Todo S; Tzakis A
Strategy of FK 506 therapy in liver transplant patients: effect of graft function.
Transplantation proceedings 1991;23(6):2771-4.
1991: Abu-Elmagd K M; Fung J; Draviam R; Shannon W; Jain A; Alessiani M; Takaya S; Venkataramanan R; Warty V S; Tzakis A
Four-hour versus 24-hour intravenous infusion of FK 506 in liver transplantation.
Transplantation proceedings 1991;23(6):2767-70.
1991: Venkataramanan R; Jain A; Warty V S; Abu-Elmagd K; Alessiani M; Lever J; Krajak A; Flowers J; Mehta S; Zuckerman S
Pharmacokinetics of FK 506 in transplant patients.
Transplantation proceedings 1991;23(6):2736-40.
1991: Abu-Elmagd K; Fung J J; Alessiani M; Jain A; Venkataramanan R; Warty V S; Takaya S; Todo S; Shannon W D; Starzl T E
The effect of graft function on FK506 plasma levels, dosages, and renal function, with particular reference to the liver.
Transplantation 1991;52(1):71-7.
1991: Fung J J; Todo S; Tzakis A; Alessiani M; Abu-Elmagd K; Jain A; Bronster O; Martin M; Gordon R; Starzl T E
Current status of FK 506 in liver transplantation.
Transplantation proceedings 1991;23(3):1902-5.
1991: Fung J J; Todo S; Tzakis A; Demetris A; Jain A; Abu-Elmaged K; Alessiani M; Starzl T E
Conversion of liver allograft recipients from cyclosporine to FK 506-based immunosuppression: benefits and pitfalls.
Transplantation proceedings 1991;23(1 Pt 1):14-21.
1991: Kusne S; Martin M; Shapiro R; Jordan M; Fung J; Alessiani M; Jain A; Todo S; Starzl T
Early infections in kidney transplant recipients under FK 506.
Transplantation proceedings 1991;23(1 Pt 2):956-7.
1991: Venkataramanan R; Jain A; Warty V W; Abu-Elmagd K; Furakawa H; Imventarza O; Fung J; Todo S; Starzl T E
Pharmacokinetics of FK 506 following oral administration: a comparison of FK 506 and cyclosporine.
Transplantation proceedings 1991;23(1 Pt 2):931-3.
1991: Alessiani M; Kusne S; Martin M; Jain A; Abu-Elmagd K; Moser J; Todo S; Fung J; Starzl T
Infections in adult liver transplant patients under FK 506 immunosuppression.
Transplantation proceedings 1991;23(1 Pt 2):1501-3.
1991: McCauley J; Takaya S; Fung J; Tzakis A; Abu-Elmagd K; Jain A; Todo S; Starzl T E
The question of FK 506 nephrotoxicity after liver transplantation.
Transplantation proceedings 1991;23(1 Pt 2):1444-7.
1991: Zeevi A; Eiras G; Kaufman C; Alessiani M; Demetris A J; Abu-Elmagd K; Jain A; Warty V; Venkataramanan R; Burckart G
Correlation between bioassayed plasma levels of FK 506 and lymphocyte growth from liver transplant biopsies with histological evidence of rejection.
Transplantation proceedings 1991;23(1 Pt 2):1406-8.
1991: Todo S; Fung J J; Tzakis A; Demetris A J; Jain A; Alessiani M; Takaya S; Day R; Gordon R; Starzl T E
One hundred ten consecutive primary orthotopic liver transplants under FK 506 in adults.
Transplantation proceedings 1991;23(1 Pt 2):1397-402.
1990: Todo S; Fung J J; Starzl T E; Tzakis A; Demetris A J; Kormos R; Jain A; Alessiani M; Takaya S; Shapiro R
Liver, kidney, and thoracic organ transplantation under FK 506.
Annals of surgery 1990;212(3):295-305; discussion 306-7.
1990: Burckart G J; Jain A; Diven W; Venkataramanan R; Starzl T E
Cyclosporine measurement by FPIA, PC-RIA, and HPLC following liver transplantation.
Transplantation proceedings 1990;22(3):1319-22.
1990: Zeevi A; Eiras G; Burckart G; Jain A; Kragack A; Venkataramanan R; Todo S; Fung J; Starzl T E; Duquesnoy R J
Bioassay of plasma specimens from liver transplant patients on FK 506 immunosuppression.
Transplantation proceedings 1990;22(1):60-3.
1990: Fung J J; Todo S; Jain A; McCauley J; Alessiani M; Scotti C; Starzl T E
Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications.
Transplantation proceedings 1990;22(1):6-12.
1990: Venkataramanan R; Jain A; Cadoff E; Warty V; Iwasaki K; Nagase K; Krajack A; Imventarza O; Todo S; Fung J J
Pharmacokinetics of FK 506: preclinical and clinical studies.
Transplantation proceedings 1990;22(1):52-6.
1990: Staschak S; Wagner S; Block G; Van Thiel D H; Jain A; Fung J; Todo S; Starzl T E
A cost comparison of liver transplantation with FK 506 or CyA as the primary immunosuppressive agent.
Transplantation proceedings 1990;22(1):47-9.
1990: Alessiani M; Kusne S; Martin F M; Fung J J; Jain A; Todo S; Simmons R; Starzl T E
Infections with FK 506 immunosuppression: preliminary results with primary therapy.
Transplantation proceedings 1990;22(1):44-6.
1990: Mieles L; Todo S; Fung J J; Jain A; Furukawa H; Susuki M; Starzl T E
Oral glucose tolerance test in liver recipients treated with FK 506.
Transplantation proceedings 1990;22(1):41-3.
1990: Van Thiel D H; Iqbal M; Jain A; Fung J; Todo S; Starzl T E
Gastrointestinal and metabolic problems associated with immunosuppression with either CyA or FK 506 in liver transplantation.
Transplantation proceedings 1990;22(1):37-40.
1990: McCauley J; Fung J; Jain A; Todo S; Starzl T E
The effects of FK 506 on renal function after liver transplantation.
Transplantation proceedings 1990;22(1):17-20.
1990: Todo S; Fung J J; Demetris A J; Jain A; Venkataramanan R; Starzl T E
Early trials with FK 506 as primary treatment in liver transplantation.
Transplantation proceedings 1990;22(1):13-6.
1990: Fung J J; Abu-Elmagd K; Todo S; Shapiro R; Tzakis A; Jordan M; Armitage J; Jain A; Alessiani M; Martin M
Overview of FK506 in transplantation.
Clinical transplants 1990;():115-21.
1989: Starzl T E; Todo S; Fung J; Demetris A J; Venkataramman R; Jain A
FK 506 for liver, kidney, and pancreas transplantation.
Lancet 1989;2(8670):1000-4.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Ashok Jain

Research Profile (preview)

Procedures

Chemicals & Drugs

Physiology

Concepts & Ideas

Anatomy

Living Beings

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Ashok Jain (preview)

All Publications